Praxis Precision Medicines, Inc. (PRAX) Reports Q2 Loss, Lags Revenue Estimates

Praxis Precision Medicines, Inc. (PRAX) came out with a quarterly loss of $1.74 per share versus the Zacks Consensus Estimate of a loss of$ 2.38. This compares to loss of $7.35 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 26.89%. A quarter ago, it was expected that this company would post a loss of$ 2.01 per share when it actually produced a loss of $2.84, delivering a surprise of -41.29%. Over the last four quarters, the ...